HSK26784

N/A

Report date: 2023/04/23 16:11:19
NME

Base Information

Drug NameHSK26784
Drug Alias NameHSK-26784
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionTyrosine-protein kinase BTK inhibitorsProteolysis
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsLeukemia, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHaisco Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHaisco Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A